Summary

Medical Marijuana Market, Product Type (Oil & Capsules, Flower, Vape & Patch Topicals, Other), Application (Neurological Conditions, Mental Health, Pain & Appetite, Digestive Issues, Cancer, Other), Source (Synthetic, Natural), Derivatives (Cannabigerol (CBG), Cannabicyclol (CBL), Cannabidiol (CBD), Cannabichromene (CBC), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabinol (CBN)), Treatment Type (Aphrodisiac, Expectorant, Psychedelic, Analgesic, Antiviral, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, Others), Distribution Channel (B2B, B2C), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 ? 2035
The Medical Marijuana market accounted for USD 31.2 billion in 2024 and is expected to reach USD 270.6 billion by 2035, growing at a CAGR of around 21.7% between 2025 and 2035. The Medical Marijuana is about growing, producing, distributing, and consuming cannabis and its derivatives for therapeutic purposes. It will be required by patients who suffer from chronic disorders like cancer, epilepsy, arthritis, and other neurological disorders. The much scientific legitimation of the medicine itself has increased acceptance by the medical people as well as regulators at large. Governments around the world are enacting legislation through supportive policies, thus putting the legal and commercial aspects into account. The market is growing steadily as innovation in formulation, delivery systems, and personalized treatment continues. Awareness rises, as well as demand from patients, and continues to make investments and research remain on tap. In a broad sense, the industry promises high potential with global expansion, increased mainstreaming, and evidence-based application adoption.
Increase in Acceptance of Medical Cannabis
The move toward recognition of the therapeutic benefits of cannabis has translated to its acceptance among medical practitioners in the mainstream. Providers are now beginning to prescribe medical marijuana for conditions like chronic pain, epilepsy, and multiple sclerosis. Active studies being carried out and good patient responses are encouraging this change. Diminishing stigma in society has made many patients open to considering cannabis-based treatment options. Furthermore, such acceptance is also fueled by approval from respected medical associations. As a result, the demand for medical marijuana is continually increasing, and there is an appetite for growth across the market.
Regulatory Challenges and Inconsistencies
Regulatory issues are now being met, even though the industry of medical marijuana industry has made some progress. From state to state, the inconsistencies generate complications for producers and distributors alike. The different compliance requirements are usually quite expensive to navigate, thus serving as a subsequent deterrent for market entry. And some countries still adhere boldly to the strict controls limiting research and commercialization. These regulatory divergences are thus creating serious bottlenecks for the seamless growth of the medical marijuana market. Addressing said difficulties is key for the industry to grow in the future.
Technological Advances in Product Development
Extraction and formulation technologies are creating breakthroughs with medical marijuana products. State-of-the-art delivery systems, namely transdermal patches and nanoemulsions, assure enhanced bioavailability and patient adherence. Such advancements in technology pave the way for targeted therapy toward specific medical conditions. The precision dosing of standardized products also enhances treatment efficiency. The continuous progression of technology now opens the door for product differentiation and market segmentation. Companies that adapt to these innovations put themselves at the forefront of the industry.
Segment Analysis
Medical marijuana carries potential benefits applicable both as symptomatic relief and as treatment for different diseases. Symptomatic treatments would, therefore, include the relief of symptoms; these include chronic pain, muscle spasms, nausea, and insomnia. This is the condition seen mostly among cancer, HIV/AIDS, and neurological disorders. Disease-targeted therapies being proposed are also targeted at conditions such as epilepsy, PTSD, and inflammatory conditions. Most patients tend to prefer using cannabis when medicines have side effects or are ineffective. Personalized treatment plans have been developed more often as patient responses may vary depending on genetics and condition. The ability to support multiple treatment approaches broadens the clinical relevance of this market. This bi-utility position thus increases acceptance by both patients and healthcare providers.
Medical marijuana thus spans numerous health conditions such as cancer, chronic pain, neurological disorders, and mental health issues. In oncology, it is indicated for treating chemotherapy-induced nausea and pain. Among patients with epilepsy, compounds from cannabis have been observed to reduce seizure frequency. Anxiety, PTSD, and depression are other areas where cannabis therapy has manifested a measure of hope when conventional medications are ineffective. Cannabis treatment, both topically and orally, is frequently employed for musculoskeletal disorders like arthritis. The increasing number of applications verified for clinical interest and funding into research contributes hugely to growth in the market and diversification. This wide-range use of medical marijuana would fortify the proposition of value in modern therapeutics.
Regional Analysis
North America is a leader in the medical marijuana market. With structured medical cannabis programs in place, the U.S. and Canada enhance clinical research and commercial activity. The vast, well-established infrastructure of cultivation, processing, and distribution supports the steady supply and innovative product development. With public awareness and physician acceptance, medical marijuana has been demystified and widely used, especially in chronic and palliative care. Despite the unsteady regulatory framework created by state and federal laws across the region, there remains a steady demand for these products. Strategic partnerships and mergers among key direct players will further consolidate their market position. North America continues to evolve as a great hub of innovation and sets trends for global markets.
Competitive Landscape
The medical marijuana sector is a patchwork of established cannabis firms, pharma firms, and biotech startups. The major players are innovating new products such as extracts of higher purity, proprietary delivery systems, and formulations tailored to specific conditions. Commonly, mergers, acquisitions, and collaborations allow companies to grow their footprints and improve R&D capabilities across the globe. Many invest in clinical trials aimed at building credibility and obtaining regulatory approval. The importance of branding and consumer education cannot be overstated when looking at winning the trust and loyalty of consumers. Some big players have chosen to vertically integrate from cultivation to distribution. The market is still in flux, with new entrants creeping in now and then to stir up competition and drive innovation.
Report Coverage:
Product Type
- Oil & Capsules
- Flower
- Vape & Patch Topicals
- Other
Application
- Neurological Conditions
- Mental Health
- Pain & Appetite
- Digestive Issues
- Cancer
- Other
Source
- Synthetic
- Natural
Derivatives
- Cannabigerol (CBG)
- Cannabicyclol (CBL)
- Cannabidiol (CBD)
- Cannabichromene (CBC)
- Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
- Cannabinol (CBN)
Treatment Type
- Aphrodisiac
- Expectorant
- Psychedelic
- Analgesic
- Antiviral
- Others
Route of Administration
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
Distribution Channel
- B2B
- B2C
End User
- Pharmaceutical Industry
- Research and Development Centers
- Homecare Setting
- Hospital
- Rehab Centers

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Global Medical Marijuana Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Growing acceptance of medical marijuana and its legalization in various regions
3.2.2. Ongoing R&D leading to new and improved medical marijuana products and delivery methods.
3.2.3. Rising prevalence of chronic and terminal illnesses driving demand for medical marijuana.
3.3. Key industry pitfalls & challenges
3.3.1. Complex and varying regulations across regions can impede market growth and product availability.
3.3.2. Expensive products and treatment costs can limit accessibility for some patients.
3.3.3. Lack of comprehensive insurance coverage for medical marijuana treatments.
3.4. Market Opportunities
3.4.1. Expanding into new geographic regions where medical marijuana is becoming legalized or is under consideration.
3.4.2. Opportunities for integrating medical marijuana with conventional treatments for a holistic approach.
3.4.3. Growth in personalized medicine approaches tailoring treatments to individual patient profiles and needs.
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Pipeline Analysis
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Medical Marijuana Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Oil & Capsules
4.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.3. Flower
4.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.4. Vape & Patch Topicals
4.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
4.5. Others
4.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5. Medical Marijuana Market, Application Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Application, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Neurological Conditions
5.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.3. Mental Health
5.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.4. Pain & Appetite
5.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.5. Digestive Issues
5.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.6. Cancer
5.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
5.7. Other
5.7.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6. Medical Marijuana Market, Source Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Source, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Synthetic
6.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
6.3. Natural
6.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7. Medical Marijuana Market, Derivatives Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Derivatives, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Cannabigerol (CBG)
7.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.3. Cannabicyclol (CBL)
7.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.4. Cannabidiol (CBD)
7.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.5. Cannabichromene (CBC)
7.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.6. Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol
7.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
7.7. Cannabinol (CBN)
7.7.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8. Medical Marijuana Market, Treatment Type Segment Analysis
8.1. Overview
8.1.1. Market Revenue Share, By Treatment Type, 2025 & 2035
8.1.2. Key Market Trends, Growth Factors, & Opportunities
8.2. Aphrodisiac
8.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8.3. Expectorant
8.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8.4. Psychedelic
8.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8.5. Analgesic
8.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8.6. Antiviral
8.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
8.7. Others
8.7.1. Market Size and Forecast, By 2025-2035 (USD Billion)
9. Medical Marijuana Market, Route of Administration Segment Analysis
9.1. Overview
9.1.1. Market Revenue Share, By Route of Administration, 2025 & 2035
9.1.2. Key Market Trends, Growth Factors, & Opportunities
9.2. Oral Solutions and Capsules
9.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
9.3. Smoking
9.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
9.4. Vaporizers
9.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
9.5. Topicals
9.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
9.6. Others
9.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
10. Medical Marijuana Market, Distribution Channel Segment Analysis
10.1. Overview
10.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035
10.1.2. Key Market Trends, Growth Factors, & Opportunities
10.2. B2B
10.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
10.3. B2C
10.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
11. Medical Marijuana Market, End User Segment Analysis
11.1. Overview
11.1.1. Market Revenue Share, By End User, 2025 & 2035
11.1.2. Key Market Trends, Growth Factors, & Opportunities
11.2. Pharmaceutical Industry
11.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)
11.3. Research and Development Centers
11.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)
11.4. Homecare Setting
11.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)
11.5. Hospital
11.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)
11.6. Rehab Centers
11.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)
12. Medical Marijuana Market, Region Segment Analysis
12.1. Overview
12.1.1. Global Market Revenue Share, By Region, 2025 & 2035
12.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)
12.2. North America
12.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)
12.2.2. North America Market Revenue, By Product Type, 2025-2035
12.2.3. North America Market Revenue, By Application, 2025-2035
12.2.4. North America Market Revenue, By Source, 2025-2035
12.2.5. North America Market Revenue, By Derivatives, 2025-2035
12.2.6. North America Market Revenue, By Treatment Type, 2025-2035
12.2.7. North America Market Revenue, By Route of Administration, 2025-2035
12.2.8. North America Market Revenue, By Distribution Channel, 2025-2035
12.2.9. North America Market Revenue, By End User, 2025-2035
12.2.10. The U.S.
12.2.10.1. U.S. Market Revenue, By Product Type, 2025-2035
12.2.10.2. U.S. Market Revenue, By Application, 2025-2035
12.2.10.3. U.S. Market Revenue, By Source, 2025-2035
12.2.10.4. U.S. Market Revenue, By Derivatives, 2025-2035
12.2.10.5. U.S. Market Revenue, By Treatment Type, 2025-2035
12.2.10.6. U.S. Market Revenue, By Route of Administration, 2025-2035
12.2.10.7. U.S. Market Revenue, By Distribution Channel, 2025-2035
12.2.10.8. U.S. Market Revenue, By End User, 2025-2035
12.2.11. Canada
12.2.11.1. Canada Market Revenue, By Product Type, 2025-2035
12.2.11.2. Canada Market Revenue, By Application, 2025-2035
12.2.11.3. Canada Market Revenue, By Source, 2025-2035
12.2.11.4. Canada Market Revenue, By Derivatives, 2025-2035
12.2.11.5. Canada Market Revenue, By Treatment Type, 2025-2035
12.2.11.6. Canada Market Revenue, By Route of Administration, 2025-2035
12.2.11.7. Canada Market Revenue, By Distribution Channel, 2025-2035
12.2.11.8. Canada Market Revenue, By End User, 2025-2035
12.3. Europe
12.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)
12.3.2. Europe Market Revenue, By Product Type, 2025-2035
12.3.3. Europe Market Revenue, By Application, 2025-2035
12.3.4. Europe Market Revenue, By Source, 2025-2035
12.3.5. Europe Market Revenue, By Derivatives, 2025-2035
12.3.6. Europe Market Revenue, By Treatment Type, 2025-2035
12.3.7. Europe Market Revenue, By Route of Administration, 2025-2035
12.3.8. Europe Market Revenue, By Distribution Channel, 2025-2035
12.3.9. Europe Market Revenue, By End User, 2025-2035
12.3.10. Germany
12.3.10.1. Germany Market Revenue, By Product Type, 2025-2035
12.3.10.2. Germany Market Revenue, By Application, 2025-2035
12.3.10.3. Germany Market Revenue, By Source, 2025-2035
12.3.10.4. Germany Market Revenue, By Derivatives, 2025-2035
12.3.10.5. Germany Market Revenue, By Treatment Type, 2025-2035
12.3.10.6. Germany Market Revenue, By Route of Administration, 2025-2035
12.3.10.7. Germany Market Revenue, By Distribution Channel, 2025-2035
12.3.10.8. Germany Market Revenue, By End User, 2025-2035
12.3.11. France
12.3.11.1. France Market Revenue, By Product Type, 2025-2035
12.3.11.2. France Market Revenue, By Application, 2025-2035
12.3.11.3. France Market Revenue, By Source, 2025-2035
12.3.11.4. France Market Revenue, By Derivatives, 2025-2035
12.3.11.5. France Market Revenue, By Treatment Type, 2025-2035
12.3.11.6. France Market Revenue, By Route of Administration, 2025-2035
12.3.11.7. France Market Revenue, By Distribution Channel, 2025-2035
12.3.11.8. France Market Revenue, By End User, 2025-2035
12.3.12. U.K.
12.3.12.1. U.K. Market Revenue, By Product Type, 2025-2035
12.3.12.2. U.K. Market Revenue, By Application, 2025-2035
12.3.12.3. U.K Market Revenue, By Source, 2025-2035
12.3.12.4. U.K Market Revenue, By Derivatives, 2025-2035
12.3.12.5. U.K Market Revenue, By Treatment Type, 2025-2035
12.3.12.6. U.K. Market Revenue, By Route of Administration, 2025-2035
12.3.12.7. U.K. Market Revenue, By Distribution Channel, 2025-2035
12.3.12.8. U.K. Market Revenue, By End User, 2025-2035
12.3.13. Italy
12.3.13.1. Italy Market Revenue, By Product Type, 2025-2035
12.3.13.2. Italy Market Revenue, By Application, 2025-2035
12.3.13.3. Italy Market Revenue, By Source, 2025-2035
12.3.13.4. Italy Market Revenue, By Derivatives, 2025-2035
12.3.13.5. Italy Market Revenue, By Treatment Type, 2025-2035
12.3.13.6. Italy Market Revenue, By Route of Administration, 2025-2035
12.3.13.7. Italy Market Revenue, By Distribution Channel, 2025-2035
12.3.13.8. Italy Market Revenue, By End User, 2025-2035
12.3.13.9.
12.3.14. Spain
12.3.14.1. Spain Market Revenue, By Product Type, 2025-2035
12.3.14.2. Spain Market Revenue, By Application, 2025-2035
12.3.14.3. Spain Market Revenue, By Source, 2025-2035
12.3.14.4. Spain Market Revenue, By Derivatives, 2025-2035
12.3.14.5. Spain Market Revenue, By Treatment Type, 2025-2035
12.3.14.6. Spain Market Revenue, By Route of Administration, 2025-2035
12.3.14.7. Spain Market Revenue, By Distribution Channel, 2025-2035
12.3.14.8. Spain Market Revenue, By End User, 2025-2035
12.3.15. Rest of Europe
12.3.15.1. Germany Market Revenue, By Product Type, 2025-2035
12.3.15.2. Germany Market Revenue, By Application, 2025-2035
12.3.15.3. Germany Market Revenue, By Source, 2025-2035
12.3.15.4. Germany Market Revenue, By Derivatives, 2025-2035
12.3.15.5. Germany Market Revenue, By Treatment Type, 2025-2035
12.3.15.6. Germany Market Revenue, By Route of Administration, 2025-2035
12.3.15.7. Germany Market Revenue, By Distribution Channel, 2025-2035
12.3.15.8. Germany Market Revenue, By End User, 2025-2035
12.4. Asia Pacific
12.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)
12.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
12.4.3. Asia Pacific Market Revenue, By Application, 2025-2035
12.4.4. Asia Pacific Market Revenue, By Source, 2025-2035
12.4.5. Asia Pacific Market Revenue, By Derivatives, 2025-2035
12.4.6. Asia Pacific Market Revenue, By Treatment Type, 2025-2035
12.4.7. Asia Pacific Market Revenue, By Route of Administration, 2025-2035
12.4.8. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
12.4.9. Asia Pacific Market Revenue, By End User, 2025-2035
12.4.10. China
12.4.10.1. China Market Revenue, By Product Type, 2025-2035
12.4.10.2. China Market Revenue, By Application, 2025-2035
12.4.10.3. China Market Revenue, By Source, 2025-2035
12.4.10.4. China Market Revenue, By Derivatives, 2025-2035
12.4.10.5. China Market Revenue, By Treatment Type, 2025-2035
12.4.10.6. China Market Revenue, By Route of Administration, 2025-2035
12.4.10.7. China Market Revenue, By Distribution Channel, 2025-2035
12.4.10.8. China Market Revenue, By End User, 2025-2035
12.4.11. Japan
12.4.11.1. Japan Market Revenue, By Product Type, 2025-2035
12.4.11.2. Japan Market Revenue, By Application, 2025-2035
12.4.11.3. Japan Market Revenue, By Source, 2025-2035
12.4.11.4. Japan Market Revenue, By Derivatives, 2025-2035
12.4.11.5. Japan Market Revenue, By Treatment Type, 2025-2035
12.4.11.6. Japan Market Revenue, By Route of Administration, 2025-2035
12.4.11.7. Japan Market Revenue, By Distribution Channel, 2025-2035
12.4.11.8. Japan Market Revenue, By End User, 2025-2035
12.4.12. India
12.4.12.1. India Market Revenue, By Product Type, 2025-2035
12.4.12.2. India Market Revenue, By Application, 2025-2035
12.4.12.3. India Market Revenue, By Source, 2025-2035
12.4.12.4. India Market Revenue, By Derivatives, 2025-2035
12.4.12.5. India Market Revenue, By Treatment Type, 2025-2035
12.4.12.6. India Market Revenue, By Route of Administration, 2025-2035
12.4.12.7. India Market Revenue, By Distribution Channel, 2025-2035
12.4.12.8. India Market Revenue, By End User, 2025-2035
12.4.13. Australia
12.4.13.1. Australia Market Revenue, By Product Type, 2025-2035
12.4.13.2. Australia Market Revenue, By Application, 2025-2035
12.4.13.3. Australia Market Revenue, By Source, 2025-2035
12.4.13.4. Australia Market Revenue, By Derivatives, 2025-2035
12.4.13.5. Australia Market Revenue, By Treatment Type, 2025-2035
12.4.13.6. Australia Market Revenue, By Route of Administration, 2025-2035
12.4.13.7. Australia Market Revenue, By Distribution Channel, 2025-2035
12.4.13.8. Australia Market Revenue, By End User, 2025-2035
12.4.14. South Korea
12.4.14.1. South Korea Market Revenue, By Product Type, 2025-2035
12.4.14.2. South Korea Market Revenue, By Application, 2025-2035
12.4.14.3. South Korea Market Revenue, By Source, 2025-2035
12.4.14.4. South Korea Market Revenue, By Derivatives, 2025-2035
12.4.14.5. South Korea Market Revenue, By Treatment Type, 2025-2035
12.4.14.6. South Korea Market Revenue, By Route of Administration, 2025-2035
12.4.14.7. South Korea Market Revenue, By Distribution Channel, 2025-2035
12.4.14.8. South Korea Market Revenue, By End User, 2025-2035
12.4.15. Singapore
12.4.15.1. Singapore Market Revenue, By Product Type, 2025-2035
12.4.15.2. Singapore Market Revenue, By Application, 2025-2035
12.4.15.3. Singapore Canada Market Revenue, By Source, 2025-2035
12.4.15.4. Singapore Market Revenue, By Derivatives, 2025-2035
12.4.15.5. Singapore Market Revenue, By Treatment Type, 2025-2035
12.4.15.6. Singapore Market Revenue, By Route of Administration, 2025-2035
12.4.15.7. Singapore Market Revenue, By Distribution Channel, 2025-2035
12.4.15.8. Singapore Market Revenue, By End User, 2025-2035
12.4.16. Rest of Asia Pacific
12.4.16.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
12.4.16.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035
12.4.16.3. Rest of Asia Pacific Market Revenue, By Source, 2025-2035
12.4.16.4. Rest of Asia Pacific Market Revenue, By Derivatives, 2025-2035
12.4.16.5. Rest of Asia Pacific Market Revenue, By Treatment Type, 2025-2035
12.4.16.6. Rest of Asia Pacific Market Revenue, By Route of Administration, 2025-2035
12.4.16.7. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035
12.4.16.8. Rest of Asia Pacific Market Revenue, By End User, 2025-2035
12.5. Latin America
12.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)
12.5.2. Latin America Market Revenue, By Product Type, 2025-2035
12.5.3. Latin America Market Revenue, By Application, 2025-2035
12.5.4. Latin America Market Revenue, By Source, 2025-2035
12.5.5. Latin America Market Revenue, By Derivatives, 2025-2035
12.5.6. Latin America Market Revenue, By Treatment Type, 2025-2035
12.5.7. Latin America Market Revenue, By Route of Administration, 2025-2035
12.5.8. Latin America Market Revenue, By Distribution Channel, 2025-2035
12.5.9. Latin America Market Revenue, By End User, 2025-2035
12.5.9.1. Brazil Market Revenue, By Product Type, 2025-2035
12.5.9.2. Brazil Market Revenue, By Application, 2025-2035
12.5.9.3. Brazil Market Revenue, By Source, 2025-2035
12.5.9.4. Brazil Market Revenue, By Derivatives, 2025-2035
12.5.9.5. Brazil Market Revenue, By Treatment Type, 2025-2035
12.5.9.6. Brazil Market Revenue, By Route of Administration, 2025-2035
12.5.9.7. Brazil Market Revenue, By Distribution Channel, 2025-2035
12.5.9.8. Brazil Market Revenue, By End User, 2025-2035
12.5.10. Argentina
12.5.10.1. Argentina Market Revenue, By Product Type, 2025-2035
12.5.10.2. Argentina Market Revenue, By Application, 2025-2035
12.5.10.3. Argentina Market Revenue, By Source, 2025-2035
12.5.10.4. Argentina Market Revenue, By Derivatives, 2025-2035
12.5.10.5. Argentina Market Revenue, By Treatment Type, 2025-2035
12.5.10.6. Argentina Market Revenue, By Route of Administration, 2025-2035
12.5.10.7. Argentina Market Revenue, By Distribution Channel, 2025-2035
12.5.10.8. Argentina Market Revenue, By End User, 2025-2035
12.5.11. Mexico
12.5.11.1. Mexico Market Revenue, By Product Type, 2025-2035
12.5.11.2. Mexico Market Revenue, By Application, 2025-2035
12.5.11.3. Mexico Market Revenue, By Source, 2025-2035
12.5.11.4. Mexico Market Revenue, By Derivatives, 2025-2035
12.5.11.5. Mexico Market Revenue, By Treatment Type, 2025-2035
12.5.11.6. Mexico Market Revenue, By Route of Administration, 2025-2035
12.5.11.7. Mexico Market Revenue, By Distribution Channel, 2025-2035
12.5.11.8. Mexico Market Revenue, By End User, 2025-2035
12.5.12. Rest of Latin America
12.5.12.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
12.5.12.2. Rest of Latin America Market Revenue, By Application, 2025-2035
12.5.12.3. Rest of Latin America Market Revenue, By Source, 2025-2035
12.5.12.4. Rest of Latin America Market Revenue, By Derivatives, 2025-2035
12.5.12.5. Rest of Latin America Market Revenue, By Treatment Type, 2025-2035
12.5.12.6. Rest of Latin America Market Revenue, By Route of Administration, 2025-2035
12.5.12.7. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035
12.5.12.8. Rest of Latin America Market Revenue, By End User, 2025-2035
12.6. MEA
12.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)
12.6.2. MEA Market Revenue, By Product Type, 2025-2035
12.6.3. MEA Market Revenue, By Application, 2025-2035
12.6.4. MEA Market Revenue, By Source, 2025-2035
12.6.5. MEA Market Revenue, By Derivatives, 2025-2035
12.6.6. MEA Market Revenue, By Treatment Type, 2025-2035
12.6.7. MEA Market Revenue, By Route of Administration, 2025-2035
12.6.8. MEA Market Revenue, By Distribution Channel, 2025-2035
12.6.9. MEA Market Revenue, By End User, 2025-2035
12.6.10. GCC Countries
12.6.10.1. GCC Countries Market Revenue, By Product Type, 2025-2035
12.6.10.2. GCC Countries Market Revenue, By Application, 2025-2035
12.6.10.3. GCC Countries Market Revenue, By Source, 2025-2035
12.6.10.4. GCC Countries Market Revenue, By Derivatives, 2025-2035
12.6.10.5. GCC Countries Market Revenue, By Treatment Type, 2025-2035
12.6.10.6. GCC Countries Market Revenue, By Route of Administration, 2025-2035
12.6.10.7. GCC Countries Market Revenue, By Distribution Channel, 2025-2035
12.6.10.8. GCC Countries Market Revenue, By End User, 2025-2035
12.6.11. South Africa
12.6.11.1. South Africa Countries Market Revenue, By Product Type, 2025-2035
12.6.11.2. South Africa Countries Market Revenue, By Application, 2025-2035
12.6.11.3. South Africa Countries Market Revenue, By Source, 2025-2035
12.6.11.4. South Africa Countries Market Revenue, By Derivatives, 2025-2035
12.6.11.5. South Africa Countries Market Revenue, By Treatment Type, 2025-2035
12.6.11.6. South Africa Countries Market Revenue, By Route of Administration, 2025-2035
12.6.11.7. South Africa Countries Market Revenue, By Distribution Channel, 2025-2035
12.6.11.8. South Africa Countries Market Revenue, By End User, 2025-2035
12.6.12. Rest of Middle-East Africa
12.6.12.1. Rest of Middle-East Africa Countries Market Revenue, By Product Type, 2025-2035
12.6.12.2. Rest of Middle-East Africa Countries Market Revenue, By Application, 2025-2035
12.6.12.3. Rest of Middle-East Africa Countries Market Revenue, By Source, 2025-2035
12.6.12.4. Rest of Middle-East Africa Countries Market Revenue, By Derivatives, 2025-2035
12.6.12.5. Rest of Middle-East Africa Countries Market Revenue, By Treatment Type, 2025-2035
12.6.12.6. Rest of Middle-East Africa Countries Market Revenue, By Route of Administration, 2025-2035
12.6.12.7. Rest of Middle-East Africa Countries Market Revenue, By Distribution Channel, 2025-2035
12.6.12.8. Rest of Middle-East Africa Countries Market Revenue, By End User, 2025-2035
13. Company Profile
13.1. Aurora Cannabis
13.1.1. Business Overview
13.1.2. Financial Performance
13.1.3. Product/Service Offerings
13.1.4. Strategies & recent developments
13.1.5. SWOT Analysis
13.2. Aphria Inc.
13.2.1. Business Overview
13.2.2. Financial Performance
13.2.3. Product/Service Offerings
13.2.4. Strategies & recent developments
13.2.5. SWOT Analysis
13.3. BOL Pharma
13.3.1. Business Overview
13.3.2. Financial Performance
13.3.3. Product/Service Offerings
13.3.4. Strategies & recent developments
13.3.5. SWOT Analysis
13.4. Canopy Growth Corporation
13.4.1. Business Overview
13.4.2. Financial Performance
13.4.3. Product/Service Offerings
13.4.4. Strategies & recent developments
13.4.5. SWOT Analysis
13.5. Cardiol Therapeutics
13.5.1. Business Overview
13.5.2. Financial Performance
13.5.3. Product/Service Offerings
13.5.4. Strategies & recent developments
13.5.5. SWOT Analysis
13.6. Celadon Pharmaceuticals Plc.
13.6.1. Business Overview
13.6.2. Financial Performance
13.6.3. Product/Service Offerings
13.6.4. Strategies & recent developments
13.6.5. SWOT Analysis
13.7. Enveric Biosciences
13.7.1. Business Overview
13.7.2. Financial Performance
13.7.3. Product/Service Offerings
13.7.4. Strategies & recent developments
13.7.5. SWOT Analysis
13.8. GW Pharmaceuticals plc
13.8.1. Business Overview
13.8.2. Financial Performance
13.8.3. Product/Service Offerings
13.8.4. Strategies & recent developments
13.8.5. SWOT Analysis
13.9. Insys Therapeutics Inc.
13.9.1. Business Overview
13.9.2. Financial Performance
13.9.3. Product/Service Offerings
13.9.4. Strategies & recent developments
13.9.5. SWOT Analysis
13.10. Maricann Group, Inc.
13.10.1. Business Overview
13.10.2. Financial Performance
13.10.3. Product/Service Offerings
13.10.4. Strategies & recent developments
13.10.5. SWOT Analysis
13.11. MGC Pharmaceuticals Limited
13.11.1. Business Overview
13.11.2. Financial Performance
13.11.3. Product/Service Offerings
13.11.4. Strategies & recent developments
13.11.5. SWOT Analysis
13.12. Medical Marijuana Inc.
13.12.1. Business Overview
13.12.2. Financial Performance
13.12.3. Product/Service Offerings
13.12.4. Strategies & recent developments
13.12.5. SWOT Analysis
13.13. MedReleaf Corporation
13.13.1. Business Overview
13.13.2. Financial Performance
13.13.3. Product/Service Offerings
13.13.4. Strategies & recent developments
13.13.5. SWOT Analysis
13.14. MIRA Pharmaceuticals
13.14.1. Business Overview
13.14.2. Financial Performance
13.14.3. Product/Service Offerings
13.14.4. Strategies & recent developments
13.14.5. SWOT Analysis
13.15. Pascal Biosciences
13.15.1. Business Overview
13.15.2. Financial Performance
13.15.3. Product/Service Offerings
13.15.4. Strategies & recent developments
13.15.5. SWOT Analysis
13.16. Realize Therapeutics
13.16.1. Business Overview
13.16.2. Financial Performance
13.16.3. Product/Service Offerings
13.16.4. Strategies & recent developments
13.16.5. SWOT Analysis
13.17. Tikun Olam, Ltd.
13.17.1. Business Overview
13.17.2. Financial Performance
13.17.3. Product/Service Offerings
13.17.4. Strategies & recent developments
13.17.5. SWOT Analysis
13.18. Tilray
13.18.1. Business Overview
13.18.2. Financial Performance
13.18.3. Product/Service Offerings
13.18.4. Strategies & recent developments
13.18.5. SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. GLOBAL MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 2. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR ACTIVATED CARBON, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 3. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR CARBON DERIVATIVES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 4. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR METAL OXIDES, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 5. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR CONDUCTIVE POLYMERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 6. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 7. GLOBAL MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 8. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR CONSUMER ELECTRONICS, 2025-2035 (USD BILLION)
TABLE 9. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR INDUSTRIAL, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 10. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 11. GLOBAL MEDICAL MARIJUANA MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2025-2035 (USD BILLION)
TABLE 12. NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 13. NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 14. NORTH AMERICA MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 15. U.S MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 16. U.S MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 17. CANADA MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 18. CANADA MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 19. EUROPE MEDICAL MARIJUANA MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 20. EUROPE MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 21. EUROPE MEDICAL MARIJUANA MARKET VALUE, APPLICATION, 2025-2035 (USD BILLION)
TABLE 22. GERMANY MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 23. GERMANY MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 24. U.K MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 25. U.K MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 26. FRANCE MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 27. FRANCE MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 28. ITALY MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 29. ITALY MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 30. SPAIN MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 31. SPAIN MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 32. ROE MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 33. ROE MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 34. ASIA PACIFIC MEDICAL MARIJUANA MARKET VALUE, BY COUNTRY, 2025-2035 (USD BILLION)
TABLE 35. ASIA PACIFIC MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 36. ASIA PACIFIC MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 37. CHINA MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 38. CHINA MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 39. INDIA MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 40. INDIA MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 41. JAPAN MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 42. JAPAN MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 43. REST OF APAC MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 44. REST OF APAC MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 45. REST OF WORLD MEDICAL MARIJUANA MARKET VALUE, BY TREATMENT TYPE, 2025-2035 (USD BILLION)
TABLE 46. REST OF WORLD MEDICAL MARIJUANA MARKET VALUE, BY APPLICATION, 2025-2035 (USD BILLION)
TABLE 47. CABOT(NORIT): FINANCIALS
TABLE 48. CABOT(NORIT): PRODUCTS & SERVICES
TABLE 49. CABOT(NORIT): RECENT DEVELOPMENTS
TABLE 50. KURARY CO. LTD: FINANCIALS
TABLE 51. KURARY CO. LTD: PRODUCTS & SERVICES
TABLE 52. KURARY CO. LTD: RECENT DEVELOPMENTS
TABLE 53. BAYER MATERIALSCIENCE AG: FINANCIALS
TABLE 54. BAYER MATERIALSCIENCE AG: PRODUCTS & SERVICES
TABLE 55. BAYER MATERIALSCIENCE AG: RECENT DEVELOPMENTS
TABLE 56. CALGON CARBON CORPORATION: FINANCIALS
TABLE 57. CALGON CARBON CORPORATION: PRODUCTS & SERVICES
TABLE 58. CALGON CARBON CORPORATION: RECENT DEVELOPMENTS
TABLE 59. CARBON NT&F: FINANCIALS
TABLE 60. CARBON NT&F: PRODUCTS & SERVICES
TABLE 61. CARBON NT&F: RECENT DEVELOPMENTS
TABLE 62. SHENZHEN NTP: FINANCIALS
TABLE 63. SHENZHEN NTP: PRODUCTS & SERVICES
TABLE 64. SHENZHEN NTP: RECENT DEVELOPMENTS
TABLE 65. CECA SA: FINANCIALS
TABLE 66. CECA SA: PRODUCTS & SERVICES
TABLE 67. CECA SA: RECENT DEVELOPMENTS
TABLE 68. CNANO TECHNOLOGY: FINANCIALS
TABLE 69. CNANO TECHNOLOGY: PRODUCTS & SERVICES
TABLE 70. CNANO TECHNOLOGY: RECENT DEVELOPMENTS
TABLE 71. DONAU CHEMIE GROUP: FINANCIALS
TABLE 72. DONAU CHEMIE GROUP: PRODUCTS & SERVICES
TABLE 73. DONAU CHEMIE GROUP: RECENT DEVELOPMENTS
TABLE 74. SHOWA DENKO: FINANCIALS
TABLE 75. SHOWA DENKO: PRODUCTS & SERVICES
TABLE 76. SHOWA DENKO: RECENT DEVELOPMENTS